|
Anupendra Sharma, Founder and Course Mentor
Anupendra is Partner at Siemens Venture Capital in Boston, investing in healthcare (devices, diagnostics, software and services). Anupendra founded the Startup Leadership Program, a global program for educating startup CEOs, which now has 500 Fellows and 300 startups that have raised $150MM. Anupendra was an investment banker at JPMorgan and Citigroup, M&A specialist at Siemens, and helped set up Ford Motor in India and China. He co-founded Mobile Medics, winner of the 2006 by the Global Social Venture Competition, which became an hour-long documentary by Japan Broadcasting Corporation, and was later taken over by Piramal Corporation. Anupendra also started a shrimp farm in Belize, Central America. He holds an MBA from Cornell, MS in Accounting & Finance from Manchester Business School, MS in Economics and Bachelors in Instrumentation Engineering from BITS Pilani, India, and grew up in a family of medical doctors. |
|
Hannah Goldberg, Director
Hannah is a PhD student in the Harvard/MIT Speech Hearing Bioscience and Technology program. She previously worked with Dr. Daniel Kohane in the Laboratory for Biomaterials and Drug Delivery at Boston Children’s Hospital focusing on the optimization of a single-application hydrogel drug delivery system to noninvasively treat Otitis Media. In 2016 she was accepted into Harvard's Therapeutics Graduate Program to further focus on pharmacology, toxicology and drug discovery. Her concentration in translational science has brought her to the Holt/Géléoc Lab to explore the effectiveness of gene therapy as an approach to restore auditory functioning in models of human deafness. Hannah completed her undergraduate studies in Neuroscience at Wellesley College. Before attending graduate school, she conducted research in the computational neuroscience lab of Dr. Barbara Shinn-Cunningham studying the mechanisms underlying auditory attention. |
|
Paola Abello, Director of Innovation
Paola Abello, MBA, is Director of Innovation at the Center for Primary Care. In 2015 Paola designed and launched InciteHealth, a one year intensive accelerator for primary care start-ups. Teams from around the country received funding, mentorship and participated in entrepreneurship and design thinking training as well as took part in three pitch events during the year. Currently, the Center’s innovation work is focused on providing education, training and support to medical students, post-docs and PhDs interested in creating health care startups. Paola is also working on expanding the medical school’s initiatives around innovation and entrepreneurship. |
|
Jennifer Bourgoin, Program Coordinator of Innovation
Jen is the InciteHealth Program Coordinator at the Center for Primary Care. In this role, Jennifer supports the Center’s innovation programs. Jennifer graduated from Wheaton College in 2011 and has coordinated programs for mission-driven organizations ever since. Most recently, Jennifer worked at MENTOR: The National Mentoring Partnership, where she coordinated convenings for the youth mentoring field and facilitated conversations about innovations in practice. Jennifer also developed trainings and supported MENTOR’s research to practice work. |
|
Ross Barman, Logistics
Ross is a fourth year medical student interested in research; namely, drug delivery and increasing patient safety during anesthesia. Ross studied Biology during his undergraduate education at Tufts University. Prior to joining HIC, Ross worked at the Koch Institute for Integrative Cancer Research as a member of the Langer Lab. His interest in anesthesiology, drug delivery, and translational medicine began in the Langer Lab where he was part of a team funded by the Bill & Melinda Gates Foundation that worked to make a novel drug delivery device that could reside in the GI tract and deliver medicine for a prolonged period of time. Ross worked at Lyndra as a consultant between the first and second year of medical school where the drug delivery device was being further refined. |
|
Tyler Brown, Communications
Tyler Brown is a PhD student in the Harvard John A. Paulson School of Engineering & Applied Sciences, studying Bioengineering. His thesis, under the direction of Professor Samir Mitragotri, focuses on investigating the transport of nanoparticles and other drug delivery vehicles across biological barriers (i.e. brain, intestine, skin). Tyler is interested in translating science from the bench to viable, commercial products to directly impact the lives of patients. He is an NSF GRFP Fellow and works alongside Harvard’s Office of Technology Development as a Business Development Fellow, assessing the commercialization potential of Harvard technologies. Previously, he acquired a M.S. in Biochemistry and Molecular Biology from the University of California, Santa Barbara. He also pursued an undergraduate degree in Polymer Science from the University of Southern Mississippi, developing synthetic mimics of antimicrobial peptides. |
|
Edwin Delfin, Communications
Edwin is an MMSc student in Immunology at Harvard Medical School. For his graduate thesis he is working in the lab of Dr. Shiv Pillai where he studies IgG4-Related Disease. Prior to graduate school, Edwin’s experiences collectively span the fields of healthcare and finance. He previously worked as an Associate at the Gilmartin Group where he created investor communication strategies for private and public biotechnology and medical technology companies. Prior to this, Edwin worked in Biotechnology Equity Research at Wedbush Securities where he focused on the valuation of biotechnology companies. Before he began his career in finance, he served as a combat medic in the United States Army and performed research at the University of California, Los Angeles (UCLA). Edwin completed his undergraduate studies in Neuroscience with a minor in Political Science at UCLA. He recently interned in technology equity research at a top ten global investment bank. |
|
Anh Ngo, Logistics
Anh is an Instructor of Anaesthesia and Pain Medicine Fellow at Harvard Medical School, Beth Israel Deaconess Medical Center. He has also served as Clinical Assistant Professor at the University of Southern California (USC) Keck School of Medicine in Los Angeles, CA. Dr. Ngo received his BS in the Biological Sciences, MBA with emphasis in Information Technology Management from the Paul Merage School of Business, and MD from the School of Medicine at the University of California Irvine (UCI). Anh completed his anesthesiology residency at the USC Keck School of Medicine. Anh has been involved with several companies, including a boutique real estate investment firm and a medical group merger and acquisition exit valued in the mid-eight figure range. He is also currently a member of Mass Medical Angels (MA2), a member of Harvard Medical School's Committee on Admissions, and an investment fellow at a biotechnology and life sciences hedge fund, Ascentia Asset Management. |
HIC Board Alumni
|
Andrew Ayoob, Ph.D. Harvard Medical School, HIC 2012-2017
|
|
Sofia Carlton, Scientific Strategy Fellow, Evelo Biosciences, HIC 2013-17
|
|
Harshal Zope, Principal Scientist, WaveGuide, HIC 2014-2017
|
|
Rohan Gidvani, Life Sciences Consultant, Putnam Associates, HIC 2017
|
